Cabazitaxel rechallenge at prostate-specific antigen relapse after previous cabazitaxel and docetaxel chemotherapy: case report

Clin Genitourin Cancer. 2012 Sep;10(3):207-9. doi: 10.1016/j.clgc.2012.01.011. Epub 2012 Mar 23.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bone Neoplasms / blood
  • Bone Neoplasms / diagnosis*
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary
  • Docetaxel
  • Drug Resistance, Neoplasm
  • Fatal Outcome
  • Humans
  • Male
  • Neoplasm Recurrence, Local*
  • Prednisolone / administration & dosage
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / pathology
  • Taxoids / administration & dosage
  • Treatment Outcome

Substances

  • Taxoids
  • Docetaxel
  • cabazitaxel
  • Prednisolone
  • Prostate-Specific Antigen